Latest filing published 18 Sept 2026 for Revolution Medicines, Inc., €10k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jack Anders appears in our data through filings on Revolution Medicines, Inc. shares, published by SEC (Form 4). Between 17 June 2021 and 16 September 2026, the trades on record add up to 43 filings.
Sales make up the whole of the open-market record (28 sales, €2.3M). No amount is published for 5 filings, which the totals therefore leave out. Besides market trades, the filings include 6 share grants and 9 option exercises. So far in 2026, the count stands at no purchases and 8 sales.
The newest entry dates from 18 September 2026: an open-market sale of €690k, in Revolution Medicines, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 43 declarations